Repetitive DNA and the C-Value Paradox
The onion, Allium cepa, carries roughly five times more DNA per cell than a human does. Lungfish genomes stretch to over 130 billion base pairs. That is forty times the human count. Neither organism is obviously forty times more complex than we are. This mismatch between genome size and organismal complexity is the C-value paradox. It forces a fundamental correction to how we think about genomes. The naive assumption is that genome size should scale with the number of genes an organism needs. This is because genes encode proteins, and proteins build bodies. That assumption is wrong. The reason it is wrong is one of the most important discoveries in molecular biology: most of the DNA in large eukaryotic genomes is not genic at all. It is repetitive — sequences present in tens, thousands, or millions of copies. These are arranged either in tandem arrays or scattered throughout the genome as mobile or once-mobile elements. Human DNA is roughly half repetitive sequence. The human genome contains only about 20,000 protein-coding genes, packed into barely 1.5% of the total DNA. Understanding repetitive DNA matters because it rewrites the relationship between genotype and genome. It explains why genome size cannot be used to infer complexity. It also explains why genomes balloon or shrink across evolutionary time, largely independent of gene content. And it explains why transposable elements — once dismissed as "junk" — are now understood as a major evolutionary force. They reshape regulatory networks, drive genome rearrangements, and even cause human disease through de novo insertions. This article works through the two great classes of repetitive DNA. It covers the classic experiments (renaturation kinetics, in situ hybridization, comparative genomics) that revealed them. Finally, it explains why the C-value paradox is best understood not as a paradox at all. Instead, it is a resolved puzzle with a clear molecular answer.
- Genome size (the C-value) does not correlate with organismal complexity or gene number — this mismatch is the C-value paradox.
- Most large eukaryotic genomes are dominated by repetitive DNA, not genes; humans are ~50% repeats but only ~1.5% coding exons.
- Repeats fall into two big classes: tandem repeats (satellite, minisatellite, microsatellite DNA at centromeres/telomeres) and interspersed repeats (transposable elements like LINEs, SINEs, LTR retrotransposons, DNA transposons).
- Cot analysis (Britten & Kohne, 1968) first proved that eukaryotic genomes contain highly repetitive, moderately repetitive, and single-copy DNA fractions by measuring reassociation kinetics.
- Transposable elements (discovered by Barbara McClintock in maize, 1940s–50s) can replicate independently of the host's need for more genes, inflating genome size via "selfish DNA" replication.
- The paradox resolves once you accept that genome size reflects the history of transposon accumulation and loss, not a blueprint's information content — gene number, not genome size, tracks complexity.
Genome size is set mainly by the accumulation and turnover of repetitive, largely non-coding DNA — especially transposable elements — so it decouples almost completely from gene number and organismal complexity.
The core idea
The C-value is the total amount of haploid nuclear DNA in a cell, usually expressed in picograms or megabases. Early genome biologists expected C-value to scale with developmental complexity — more sophisticated organisms should need more genetic instructions, hence more DNA. When this expectation was tested across the tree of life it failed spectacularly. Amphibians vary in C-value by over 100-fold among species of similar anatomical complexity. Some single-celled amoebae (Polychaos dubium) have C-values exceeding 600 billion base pairs, over 200 times the human genome. This decoupling of DNA content from apparent complexity is the C-value paradox, a term coined in the 1970s (largely credited to C. A. Thomas Jr.), though "paradox" is a slight misnomer — it is a puzzle that molecular biology has now largely solved. The resolution rests on the discovery that eukaryotic genomes are architecturally heterogeneous. They contain single-copy DNA (most protein-coding genes and their immediate regulatory elements), and repetitive DNA, sequences repeated many times over. Repetitive DNA itself splits into two structurally distinct categories. Tandem repeats consist of a short sequence motif repeated head-to-tail many times in a row at one genomic location — satellite DNA at centromeres, minisatellites, and microsatellites (short tandem repeats, STRs) scattered genome-wide, and rDNA arrays. Interspersed repeats, by contrast, are copies of a repeat unit scattered at many different, often unlinked, chromosomal locations; the overwhelming majority of these are derived from transposable elements (TEs) — DNA sequences that can move or copy themselves within a genome, sometimes called "jumping genes." The key conceptual move is recognizing that TEs are, in an important sense, genomic parasites or "selfish DNA": sequences that persist and proliferate because they are good at replicating themselves, not because they benefit the host organism. Once you accept that a large fraction of genomic DNA is optimized for its own propagation rather than for organismal function, the C-value paradox stops being paradoxical. Genome size becomes a record of each lineage's history of TE invasion, amplification, and purging (through deletion, recombination, and purifying selection) — a history largely independent of how many genes an organism needs to build itself. This reframing connects directly to Genome Organization Across Domains of Life, since bacteria (with small, gene-dense genomes and few TEs) and eukaryotes (with sprawling, repeat-laden genomes) sit at opposite ends of this spectrum, and it sets up why chromosomes need specialized packaging machinery, previewed in Chromosome Structure and the Mitotic Chromosome.
Mechanism
1. Tandem repeats and their genomic roles. Tandem repeats are classified largely by repeat unit length and array size. Satellite DNA consists of repeat units from a few base pairs to several hundred, arrayed in blocks of megabases, concentrated at centromeres (e.g., human alpha-satellite, a ~171-bp monomer repeated in arrays spanning 0.3–5 Mb per chromosome) and sometimes telomeres. Because satellite DNA has a distinct base composition, it often separates from bulk genomic DNA as a distinct band during cesium chloride density-gradient centrifugation — the physical basis of its name. Minisatellites have repeat units of roughly 10–60 bp and total array lengths of hundreds to a few thousand base pairs; they cluster near telomeres and are hypervariable in copy number between individuals, the basis of Alec Jeffreys' DNA fingerprinting. Microsatellites (STRs) have very short units, 1–6 bp (e.g., (CA)ₙ), repeated tens of times; they are distributed throughout the genome, mutate rapidly via polymerase slippage during replication, and are the workhorse markers of forensic genotyping and linkage mapping. Tandem repeats at centromeres provide the structural scaffold for kinetochore assembly (via the centromeric histone variant CENP-A), and telomeric repeats (TTAGGG in humans, repeated 100s–1000s of times) are added by telomerase-like mechanisms to solve the end-replication problem — both essential functions built from repetitive, low-complexity DNA, showing that not all repeats are "junk."
2. Interspersed repeats: transposable elements. TEs fall into two mechanistic classes based on how they move. Class I — retrotransposons move via an RNA intermediate: the element is transcribed into RNA, reverse-transcribed into cDNA, and the cDNA copy is inserted at a new genomic site — a "copy-and-paste" mechanism that necessarily increases copy number with every transposition event.
- LTR retrotransposons (long terminal repeats flanking the element, structurally resembling retroviruses) — abundant in plant genomes (a majority of maize's genome is LTR retrotransposon sequence).
- LINEs (Long Interspersed Nuclear Elements) — autonomous, encode their own reverse transcriptase and endonuclease. Human LINE-1 (L1) elements are ~6 kb full length, though most of the ~500,000 copies in the human genome are 5′-truncated and non-functional; roughly 80–100 copies per genome remain retrotransposition-competent.
- SINEs (Short Interspersed Nuclear Elements) — non-autonomous, ~100–300 bp, parasitize the LINE-1 machinery for their own mobilization. Human Alu elements (a SINE family, ~300 bp, derived from the 7SL RNA gene) number over 1 million copies, comprising roughly 10% of the human genome by themselves.
Class II — DNA transposons move via a DNA intermediate, often through a "cut-and-paste" mechanism: a transposase enzyme excises the element from one site and reinserts it elsewhere. These do not intrinsically increase copy number on transposition (though replicative pathways and post-excision gap repair using a sister chromatid can increase numbers). DNA transposons make up about 3% of the human genome and are almost entirely inactive (fossilized) in humans, though the Mariner/*Tc1 superfamily remains active in some insects and the domesticated piggyBac* transposase is now a workhorse of biotechnology.
3. Why this inflates genome size. Retrotransposition is inherently multiplicative: each successful "jump" of a LINE or SINE element leaves the original copy in place and adds a new copy elsewhere, so populations of active elements can expand genomes exponentially in evolutionary time until selection, epigenetic silencing (via DNA methylation and heterochromatin formation), or mutational decay checks their spread. Different lineages tolerate different levels of TE proliferation depending on effective population size and the strength of purifying selection (the mutational-hazard hypothesis of Michael Lynch), which is why genome size varies so wildly even between related species — pufferfish (Takifugu) keep an extraordinarily compact ~400 Mb genome by aggressively deleting TE-derived DNA, while related teleost genomes balloon with unchecked repeat expansion.
4. Detecting and quantifying repeats — Cot analysis. The classical method for revealing genome repeat structure is reassociation (Cot) kinetics, developed by Roy Britten and David Kohne (1968). Genomic DNA is sheared into short fragments, denatured into single strands by heat, and allowed to reanneal. The rate of reannealing depends on how many complementary partners each sequence has in the mixture: highly repetitive sequences find partners fast (low Cot₁/₂), single-copy sequences find partners slowly (high Cot₁/₂), because reassociation is a second-order chemical reaction whose rate depends on the concentration of complementary strands. Plotting the fraction of DNA reassociated against log(Cot) (initial DNA concentration × time) produces a curve with distinct kinetic components corresponding to highly repetitive, moderately repetitive, and single-copy DNA fractions — the first direct biochemical proof that eukaryotic genomes are not homogeneous mixtures of unique genes but contain large repeated fractions.
The evidence
Britten & Kohne's Cot analysis (1968). Before this work, biologists generally assumed eukaryotic genomes were, like bacterial genomes, essentially collections of unique genes. Roy Britten and David Kohne sheared calf thymus and other eukaryotic DNAs into ~400-nucleotide fragments, denatured them, and measured reassociation rates over a huge range of Cot values (DNA concentration × time, spanning many orders of magnitude). If the genome were entirely unique-sequence, the reassociation curve would show a single kinetic component. Instead, the curves showed multiple distinct components: a fraction reassociating extremely fast (consistent with sequences repeated a million-fold or more — the highly repetitive/satellite fraction), a fraction reassociating at intermediate rates (repeated hundreds to thousands of times — the "middle-repetitive" fraction, later shown to correspond largely to transposable elements like Alu), and a slow fraction corresponding to single-copy genes. This was the first direct biochemical demonstration that eukaryotic genomes contain massive amounts of repeated sequence — establishing the physical reality behind the C-value paradox, which had already been noted from measurements of total DNA content across species (work traced to Hewson Swift's 1950s cytophotometry and later synthesized by C.A. Thomas and Susumu Ohno in the 1970s, the latter popularizing the term "junk DNA").
McClintock's discovery of transposable elements (1940s–1950s). Working with maize (Zea mays) at Cold Spring Harbor, Barbara McClintock studied kernels with unstable variegated pigmentation patterns — irregular streaks and spots of color rather than uniform inheritance predicted by simple Mendelian genes. Tracking chromosome breakage at a locus she called Ds (Dissociation), she found that Ds only caused breakage when another locus, Ac (Activator), was present elsewhere in the genome — and, crucially, that both Ds and Ac could change their chromosomal position between generations. She proposed that these were mobile "controlling elements" that could insert into or excise from genes, altering their expression and explaining the variegation. This contradicted the then-dominant view of genes as fixed, immutable points on a chromosome string. Her results, published starting in 1950 and presented at the 1951 Cold Spring Harbor Symposium, were met with skepticism for decades. Confirmation came only once molecular cloning in the 1970s–80s allowed direct sequencing of Ac/*Ds* and demonstrated they were DNA transposons with terminal inverted repeats and transposase activity, exactly as her genetic data implied. McClintock was awarded the Nobel Prize in Physiology or Medicine in 1983, alone, for this discovery — an unusually long gap (over 30 years) between discovery and Nobel recognition, itself telling evidence of how radical the idea was.
Comparative genome sequencing (1990s–2000s). The final piece of evidence came from whole-genome sequencing across many species, which allowed direct annotation of repeat content rather than inference from reassociation kinetics. The Human Genome Project (2001) revealed that transposon-derived sequence makes up at least 45% of the human genome (current estimates including degraded, unrecognizable ancient copies push this toward 50–66%), while protein-coding exons make up only ~1.5%. Comparative sequencing across plants confirmed that genome size differences between closely related species (e.g., different Oryza — rice — species, or maize versus its close relative sorghum) are driven almost entirely by differential expansion of LTR retrotransposon families, not by differences in gene number, which remains roughly constant (~30,000–40,000 genes) across flowering plants regardless of genome size. This comparative genomic evidence closed the loop: the C-value paradox is explained by lineage-specific histories of TE proliferation and genome downsizing, not by any relationship between DNA quantity and biological complexity.
Worked examples
Example 1 — Reading a Cot curve. A researcher shears human genomic DNA and performs reassociation kinetics, obtaining three kinetic components with the following approximate properties:
| Fraction | % of genome | Cot₁/₂ | Interpretation |
|---|---|---|---|
| Highly repetitive | 10% | ~10⁻³ | Satellite DNA, ~10⁶ copies/genome |
| Middle repetitive | 40% | ~1–10 | SINEs/LINEs, ~10³–10⁵ copies each |
| Single copy | 50% | ~10³–10⁴ | Protein-coding + unique regulatory DNA |
Since Cot₁/₂ is inversely proportional to sequence complexity/copy number (a sequence present at N copies reassociates roughly N times faster than a single-copy sequence of the same length), a component with Cot₁/₂ a thousand-fold lower than the single-copy component corresponds to a sequence family repeated roughly a thousand-fold. Given the human genome is ~3,200 Mb, a middle-repetitive fraction of 40% corresponds to ~1,280 Mb of TE-derived sequence — consistent with the ~50% TE content directly measured by genome sequencing three decades later. This shows the power (and the limits) of the kinetic method: it correctly predicted genome architecture decades before sequencing technology existed, but could not resolve individual repeat family identities — that required cloning and, ultimately, whole-genome sequencing.
Example 2 — Estimating genome inflation from an active LINE-1 family. Suppose an ancestral mammalian genome contained a single active full-length LINE-1 element 6 kb long, and this element underwent successful retrotransposition at an average rate of 1 new insertion per element per 500,000 years (a simplified constant-rate model; real rates vary hugely and decline as elements decay), with a constant 50% of new insertions themselves remaining retrotransposition-competent (the rest are truncated/inactivated on insertion, consistent with the observation that only ~80–100 of ~500,000 human L1 copies are still active).
- After 1 round (500,000 yr): 1 active copy → 2 total copies (1 original + 1 new), 1 of which is still active.
- After each subsequent round, the active pool grows by a factor of 1.5× per round (each active copy produces 1 new copy, half of which stay active), while total copy number keeps accumulating even from now-inactive copies.
- Over 20 rounds (~10 million years), starting from 1 active copy, the active pool would grow roughly as 1.5²⁰ ≈ 3,325-fold in this idealized model — while total (mostly inactive/truncated) copy number would be far larger, since every active copy at every round contributes one permanent new insertion regardless of whether that insertion itself stays active.
This toy calculation (not a literal historical reconstruction, since real rates are heterogeneous and declining) illustrates the essential point: exponential-like, self-propagating replication of a single 6-kb element family, sustained over tens of millions of years, is sufficient to generate hundreds of thousands of genomic copies and hundreds of megabases of sequence — exactly the scale of Alu (~1.1 million copies, ~300 bp each, ≈330 Mb total) and L1 (~500,000 copies, ≈17% of the genome) in the actual human genome. No increase in gene number is required to produce a much larger genome; only unchecked replication of a mobile element is needed.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "Bigger genome = more complex organism" | Genome size (C-value) correlates poorly with complexity; onions, lungfish, and some amoebae vastly exceed the human genome in size. |
| "All repetitive DNA is junk with no function" | Some repeats are functional: centromeric satellite DNA anchors kinetochores, telomeric repeats solve end-replication, and some TE-derived sequences have been co-opted as enhancers or exons (exaptation). |
| "Transposons move to help the organism adapt" | TE proliferation is explained by selfish replication dynamics, not organismal benefit; teleological "the genome wants to adapt" framing is incorrect. |
| "Cot analysis directly sequences repeats" | Cot kinetics measures reassociation rate, revealing copy-number classes, not sequence identity; actual repeat sequences required cloning/sequencing to identify. |
| "DNA transposons and retrotransposons move the same way" | DNA transposons move via cut-and-paste (DNA intermediate, no net copy-number increase per event); retrotransposons move via copy-and-paste (RNA intermediate, net copy-number increase per event). |
| "Gene number tracks genome size" | Human and pufferfish have similar gene counts (~20,000) despite an ~8-fold difference in genome size, driven entirely by differential TE content. |
The scientist behind it
Barbara McClintock spent her career at Cold Spring Harbor Laboratory studying the cytogenetics of maize with extraordinary rigor, tracking chromosome breakage patterns visible under the microscope back to precise genetic loci through painstaking crosses. Her discovery of Ac/*Ds controlling elements in the late 1940s challenged the foundational assumption that genes occupy fixed, stable positions on chromosomes. The genetics community's initial cool reception — her ideas were seen as too radical, too complex, and difficult to reconcile with the classical gene concept — did not deter her continued work, though she largely stopped publishing on the topic for wide audiences after the 1950s, continuing careful unpublished analysis for decades. Molecular biology, once mature enough to clone and sequence maize DNA in the late 1970s and 1980s, vindicated her model precisely: Ac encodes a transposase, Ds is a non-autonomous deletion derivative of Ac that requires Ac*-supplied transposase in trans, and both carry terminal inverted repeats recognized by the transposase — the molecular signature of a cut-and-paste DNA transposon exactly as her genetic data had implied thirty years earlier.
Origins · 1 minBarbara McClintock and how this was discovered
Where this matters today
Human disease. Active human LINE-1 and Alu elements still retrotranspose in the germline and occasionally in somatic tissue, and de novo insertions have caused documented human genetic diseases, including specific cases of hemophilia A and Duchenne muscular dystrophy where an L1 insertion disrupted the relevant gene. TE reactivation is also implicated in some cancers, where loss of normal epigenetic silencing (DNA methylation) permits abnormal retrotransposition and genomic instability.
Forensic and clinical genetics. Microsatellite (STR) length polymorphisms are the molecular basis of forensic DNA profiling (e.g., the CODIS 20-locus STR panel used by the FBI) and of clinical diagnosis for trinucleotide repeat expansion diseases — Huntington's disease (CAG repeat expansion in HTT), fragile X syndrome (CGG expansion in FMR1), and myotonic dystrophy — where pathogenic expansion of a normally short tandem repeat causes disease, with repeat length often correlating with age of onset and severity (genetic anticipation).
Biotechnology. DNA transposons have been "domesticated" as laboratory and gene-therapy tools: the piggyBac and Sleeping Beauty transposon systems (the latter a reconstructed, ancestral fish transposon reactivated by mutagenesis) are widely used for stable transgene integration in cell lines, CAR-T cell engineering, and insertional mutagenesis screens, precisely exploiting the cut-and-paste mechanism McClintock first inferred genetically.
Agriculture and crop genomics. Because gene number stays roughly constant while genome size in crops is driven by TE content, breeders and genome engineers increasingly target TE-rich regions for genome-size reduction or use TE insertion polymorphisms as molecular markers for trait mapping; well-documented cases include TE insertions controlling fruit color and ripening traits in tomato and pigmentation and grain-quality traits in maize and rice.
Conservation and comparative genomics. C-value estimates and repeat content are used in genome-assembly planning (repeat-rich genomes are dramatically harder to assemble) and in phylogenetic and evolutionary studies of genome-size evolution, including tests of the mutational-hazard hypothesis linking effective population size to TE accumulation across endangered and non-model species.
Ask the tutor: How do genome-size differences between closely related species get used to estimate rates of transposable-element activity over evolutionary time?
Is all repetitive DNA "junk"?
No. While much repetitive DNA (especially degraded, ancient TE fragments) has no known function, some repeat classes are essential. Centromeric satellite DNA provides the structural platform for kinetochore assembly via CENP-A nucleosomes, telomeric repeats are the substrate for telomerase-mediated chromosome-end maintenance, and specific TE-derived sequences have been "exapted" as functional enhancers, promoters, or even entire protein-coding exons (e.g., the syncytin gene, derived from a retroviral envelope gene, essential for placental development in humans). The safest generalization is that repetitive DNA is not systematically functional or non-functional; each family and locus must be evaluated on its own evidence.
Why does the human genome need only ~20,000 genes despite being 3,200 Mb?
Gene number is set by the complexity of the organism's regulatory and protein networks, not by raw DNA quantity, and human biological complexity is achieved largely through combinatorial gene regulation, alternative splicing, and post-translational modification rather than sheer gene count. The vast majority of the remaining genome — introns, intergenic DNA, and repetitive elements — is not devoted to additional protein-coding information. This is precisely why genome size and gene number decouple: adding another copy of an already-active LINE-1 element inflates genome size without adding any new gene.
How do microsatellites cause diseases like Huntington's disease?
Certain genes contain short tandem repeats (e.g., CAG, encoding glutamine) within their coding or regulatory sequence. These repeats are unstable during DNA replication because the repetitive template can cause the replication or repair machinery to slip, adding or removing repeat units. When repeat number exceeds a pathogenic threshold — for HTT (Huntington's disease), roughly 36 or more CAG repeats — the resulting protein (or, in some diseases, the RNA itself) becomes toxic, often through aggregation. Repeat number frequently expands further across generations, explaining genetic anticipation, where disease onset gets earlier and more severe in successive generations.
Does the C-value paradox mean genome size evolution is random?
Not entirely random, but it is not driven by selection for organismal complexity either. Genome size reflects a balance between insertion (TE proliferation, which can be nearly unconstrained when selection is weak) and removal (deletion via unequal recombination, and purifying selection against harmful insertions). The mutational-hazard hypothesis (Michael Lynch) proposes that species with small effective population sizes tolerate more genome bloat because selection against mildly deleterious TE insertions is less efficient — linking population genetics, not organismal need, to genome size evolution.
How is Cot analysis different from modern genome sequencing for studying repeats?
Cot analysis measures bulk reassociation kinetics of sheared, denatured DNA and can only classify repeats into broad copy-number categories (highly repetitive, moderately repetitive, single copy) without revealing sequence identity or genomic location. Modern whole-genome sequencing directly reads every base, allowing repeats to be classified by family (Alu, L1, LTR type), dated by sequence divergence from a consensus (recently active families are more uniform), and mapped to exact chromosomal positions. Cot analysis was foundational because it was the first method sensitive enough to reveal that repeats exist at all, well before sequencing technology existed.
Are transposable elements found in all domains of life?
Yes, though their abundance varies enormously. Bacteria have insertion sequences (IS elements) and transposons but generally at low copy number, consistent with small, gene-dense bacterial genomes under strong selection against non-functional DNA (see Genome Organization Across Domains of Life). Eukaryotes show the full range, from TE-poor compact genomes (pufferfish, ~6% repeats) to TE-dominated genomes (maize ~85% TEs, some salamanders and lungfish even higher). This gradient itself is strong evidence that TE content, not gene content, is the primary driver of genome-size variation across life.
Can transposons be beneficial to the host genome?
Yes, on evolutionary timescales, even though most individual insertion events are neutral or mildly deleterious. TE-derived sequences have repeatedly been co-opted ("exapted") to provide new regulatory elements, alternative promoters, and even novel exons; well-documented cases include the domestication of a retroviral envelope gene into syncytin, essential for mammalian placenta formation, and TE-derived sequences that now function as transcription-factor binding sites in mammalian gene-regulatory networks. The domesticated transposase from the piggyBac element and the reconstructed Sleeping Beauty transposon are also human-directed uses of transposon machinery for gene delivery.